Published in J Korean Med Sci on March 28, 2011
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant (2003) 1.58
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol (2001) 1.26
Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant (2008) 1.03
Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01
Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant (2006) 1.00
Successful renal transplantation with desensitization in highly sensitized patients: a single center experience. J Korean Med Sci (2009) 0.95
Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation (2003) 0.92
The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int (1996) 0.91
Donor-specific B and T lymphocyte antibodies and kidney graft survival. Transplantation (1981) 0.90
Hyperacute and acute kidney graft rejection due to antibodies against B cells. Transplantation (1992) 0.90
Renal transplantation and B-cell cross-matches with autoantibodies and alloantibodies. Lancet (1977) 0.84
Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Transplant Proc (2006) 0.83
Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts. Predisposing factors, histology, immunohistochemistry, and relation to outcome. Transplantation (1996) 0.79
Acute vascular rejection in renal transplantation--diagnosis and outcome. Transplantation (1992) 0.79
Positive crossmatches--when is it safe to transplant? Transpl Int (1989) 0.78
Significance of B-cell crossmatch on outcome in renal transplantation. Transplant Proc (1991) 0.78
Comparison of antibody monitoring system with flow cytometric crossmatch test in renal transplant recipients with high panel-reactive antibody. Nephron Clin Pract (2009) 0.78
Renal transplantation with positive allocrossmatch (B/T; historical/current) but current T negative. Transplant Proc (1991) 0.78
Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int (2005) 3.03
Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation (2005) 1.64
Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant (2006) 1.63
Prevalence of microalbuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting. Hypertens Res (2013) 1.52
The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol (2009) 1.48
Clinical significance of preexisting microcalcification in the iliac artery in renal transplant recipients. Transplantation (2015) 1.39
Successful transplant of a kidney with fibromuscular dysplasia having higher glomerular filtration rate than the contralateral kidney. Exp Clin Transplant (2012) 1.39
Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol (2009) 1.37
Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J (2003) 1.36
The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Nephrol Dial Transplant (2011) 1.31
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant (2010) 1.29
A comparative study of methods of estimating kidney length in kidney transplantation donors. Nephrol Dial Transplant (2007) 1.27
Ultrasonographic measurement of intima-media thickness of radial artery in pre-dialysis uraemic patients: comparison with histological examination. Nephrol Dial Transplant (2005) 1.24
Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol (2010) 1.21
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Diabetes (2006) 1.21
Deep venous thrombosis caused by congenital absence of inferior vena cava, combined with hyperhomocysteinemia. Ann Vasc Surg (2004) 1.11
Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients. Am J Kidney Dis (2003) 1.08
Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS One (2013) 1.06
Cyclosporine-induced renal injury induces toll-like receptor and maturation of dendritic cells. Transplantation (2005) 1.05
Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J (2009) 1.04
Recurrent upper extremity embolism due to a crutch-induced arterial injury: a different cause of upper extremity embolism. Ann Vasc Surg (2010) 1.03
Serum albumin level correlates with disease severity in patients with Hemorrhagic Fever with Renal Syndrome. J Korean Med Sci (2003) 1.03
High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway. Nephrol Dial Transplant (2011) 1.02
Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway. J Immunol (2003) 1.01
Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol (2003) 1.00
Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant (2005) 0.99
Eleven-year experience of low grade lymphoma in Korea (based on REAL classification). Yonsei Med J (2003) 0.99
Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. J Alzheimers Dis (2012) 0.97
Acquired Gitelman syndrome in a patient with primary Sjögren syndrome. Am J Kidney Dis (2008) 0.97
Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation (2010) 0.97
Established and newly proposed mechanisms of chronic cyclosporine nephropathy. Korean J Intern Med (2009) 0.97
The first case of intraperitoneal bronchogenic cyst in Korea mimicking a gallbladder tumor. J Korean Med Sci (2004) 0.96
Downregulation of renal sodium transporters and tonicity-responsive enhancer binding protein by long-term treatment with cyclosporin A. J Am Soc Nephrol (2007) 0.96
Preconditioning with 1,25-dihydroxyvitamin D3 protects against subsequent ischemia-reperfusion injury in the rat kidney. Nephron Exp Nephrol (2005) 0.96
Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases. Nephrology (Carlton) (2005) 0.95
Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract (2004) 0.95
Successful renal transplantation with desensitization in highly sensitized patients: a single center experience. J Korean Med Sci (2009) 0.95
B cell-associated immune profiles in patients with end-stage renal disease (ESRD). Exp Mol Med (2012) 0.95
Giant aneurysm of the common hepatic artery: US and CT imaging findings. Abdom Imaging (2009) 0.95
A case of cytomegalovirus colitis in an immunocompetent hemodialysis patient. Hemodial Int (2011) 0.95
Superior mesenteric artery syndrome due to an aortic aneurysm in a renal transplant recipient. J Korean Med Sci (2002) 0.95
Age-associated molecular changes in the kidney in aged mice. Oxid Med Cell Longev (2012) 0.95
Long-term blockade of vascular endothelial growth factor receptor-2 aggravates the diabetic renal dysfunction associated with inactivation of the Akt/eNOS-NO axis. Nephrol Dial Transplant (2010) 0.95
Administration of a mutated myostatin propeptide to neonatal mice significantly enhances skeletal muscle growth. Mol Reprod Dev (2010) 0.95
Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasound technique. BMC Nephrol (2014) 0.94
Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol Lett (2011) 0.94
Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction. Transplantation (2012) 0.94
Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease. Endocr J (2010) 0.94
Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2. Nutr Metab (Lond) (2014) 0.94
The impact of intima-media thickness of radial artery on early failure of radiocephalic arteriovenous fistula in hemodialysis patients. J Korean Med Sci (2006) 0.93
Expression of ammonia transporters, Rhbg and Rhcg, in chronic cyclosporine nephropathy in rats. Nephron Exp Nephrol (2008) 0.93
Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy. Am J Nephrol (2008) 0.93
Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation. Ren Fail (2011) 0.93
Abdominal aortic calcification is associated with diastolic dysfunction, mortality, and nonfatal cardiovascular events in maintenance hemodialysis patients. J Korean Med Sci (2012) 0.92
Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy. Transpl Int (2012) 0.92
Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. J Control Release (2002) 0.92
Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. Transplantation (2003) 0.92
Interdialytic weight gain and cardiovascular outcome in incident hemodialysis patients. Am J Nephrol (2014) 0.92
Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression. PLoS One (2012) 0.92
Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation. Nephron Clin Pract (2013) 0.91